Abstract:Pregnane X receptor (PXR) is essential in the regulation of liver homeostasis, and the gut microbiota is closely linked to liver physiologic and pathologic status. We previously found that activation of PXR significantly promotes liver enlargement through interaction with yes-associated protein (YAP). However, whether gut microbiota contributes to PXR-induced hepatomegaly and the involved mechanisms remain unclear. In this study, C57BL/6 mice were administered the mouse-specific agonist pregnenolone 16α-carbonitrile (PCN) for 5 days. Depletion of gut microbiota was achieved using broad-spectrum antibiotics (ABX) and fecal microbiota transplantation (FMT) was performed to restore the gut microbia. The composition of gut microbiota was analyzed by 16S rRNA sequencing, while the expression of PXR, YAP, and their downstream target genes and proteins were assessed. The results indicated that PCN treatment altered the composition and abundance of specific bacterial taxa. Furthermore, depletion of gut microbiota using ABX significantly attenuated PCN-induced hepatomegaly. FMT experiments further demonstrated that the fecal microbiota from PCN-treated mice could induce liver enlargement. Mechanistic studies revealed that ABX treatment impeded the PXR and YAP activation induced by PCN, as evidenced by decreased expression of PXR, YAP, and their downstream targets. Moreover, alterations in PXR and YAP activation were likely contributing to hepatomegaly in recipient mice following FMT from PCN-treated mice. Collectively, the current study demonstrated that gut microbiota is involved in PCN-induced hepatomegaly via regulating PXR and YAP activation, providing potential novel insights into the involvement of gut microbiota in PXR-mediated hepatomegaly. SIGNIFICANCE STATEMENT: This work describes that the composition of gut microbiota is altered in mouse pregnane X receptor (PXR) agonist pregnenolone 16α-carbonitrile (PCN)-induced hepatomegaly. Treatment with an antibiotic cocktail depletes the intestinal microbiota, leading to the impairment of liver enlargement caused by PCN. Additionally, fecal microbiota transplantation from PCN-treated mice induces liver enlargement. Further study revealed that gut microbiota is involved in hepatomegaly via regulating PXR and yes-associated protein activation.

Gut Microbiota Affects Mouse Pregnane X Receptor Agonist Pregnenolone 16A-Carbonitrile-induced Hepatomegaly by Regulating Pregnane X Receptor and Yes-Associated Protein ActivationS

Gut Microbiota Affects Mouse Pregnane X Receptor Agonist Pregnenolone 16α-Carbonitrile-Induced Hepatomegaly by Regulating Pregnane X Receptor and Yes-Associated Protein Activation

Gut microbiota signatures and lipids metabolism profiles by exposure to polyene phosphatidylcholine.

Long-term Treatment with the Mpxr Agonist PCN Promotes Hepatomegaly and Lipid Accumulation Without Hepatocyte Proliferation in Mice.

Lipidomic Profiling Reveals Triacylglycerol Accumulation in the Liver During Pregnane X Receptor Activation-Induced Hepatomegaly.

PXR mediates mifepristone-induced hepatomegaly in mice

Pregnane X Receptor Promotes Liver Enlargement in Mice Through the Spatial Induction of Hepatocyte Hypertrophy and Proliferation

Pregnane X receptor activation induces liver enlargement and regeneration and simultaneously promotes the metabolic activity of CYP3A1/2 and CYP2C6/11 in rats

The reversal of PXR or PPARα activation-induced hepatomegaly

Pregnane X Receptor Regulates Liver Size and Liver Cell Fate via Yes-associated Protein Activation.

Understanding the physiological functions of the host xenobiotic-sensing nuclear receptors PXR and CAR on the gut microbiome using genetically modified mice

Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis

Pregnane X Receptor Activation in Liver Macrophages Protects against Endotoxin-Induced Liver Injury

Peroxisome proliferator-activated receptor α agonist induces mouse hepatomegaly through the spatial hepatocyte enlargement and proliferation

Metabolomics reveals dysregulated all-trans retinoic acid and polyunsaturated fatty acid metabolism contribute to PXR-induced hepatic steatosis in mice

Pregnane X receptor knockout mitigates weight gain and hepatic metabolic dysregulation in female C57BL/6 J mice on a long-term high-fat diet

Gut Microbiota and Liver Metabolomics Reveal the Potential Mechanism of Lactobacillus Rhamnosus GG Modulating the Liver Toxicity Caused by Polystyrene Microplastics in Mice

A Novel Pregnane X Receptor-Mediated and Sterol Regulatory Element-Binding Protein-Independent Lipogenic Pathway

Pharmacomicrobiomics of Hepatic Drug Processing Genes During Pregnancy

Activation of Pregnane X Receptor Disrupts Glucocorticoid and Mineralocorticoid Homeostasis.

Gut Microbiota As a Modulator of Paneth Cells During Parenteral Nutrition in Mice